ORZEYFUL™ (oveporexton) CIV packaging

ORZEYFUL dosing instructions1

1 mg

ORZEYFUL™ (oveporexton) CIV 1 mg packaging and tablet

2 mg

ORZEYFUL™ (oveporexton) CIV 2 mg packaging and tablet

Drug tablet and bottle images are for illustrative purposes only and are not shown to actual size.

The recommended dosage of ORZEYFUL is 1 mg or 2 mg twice daily1
ORZEYFUL may be taken with or without food1

Drug tablet and bottle images are for illustrative purposes only and are not shown to actual size.

  • The maximum recommended total daily dosage is 4 mg, orally1
  • ORZEYFUL should be stored at 68 °F to 77 °F (20 °C to 25 °C); excursions permitted from 59 °F to 86 °F (15 °C to 30 °C)1
  • The maximum recommended total daily dosage is 4 mg, orally1
  • ORZEYFUL should be stored at 68 °F to 77 °F (20 °C to 25 °C); excursions permitted from 59 °F to 86 °F (15 °C to 30 °C)1

Daytime dosing—no nighttime administration required1

Dose modifications for CYP3A inhibitors

  • ORZEYFUL is contraindicated in patients taking strong CYP3A inhibitors1
  • If ORZEYFUL is used concomitantly with moderate CYP3A inhibitors, reduce ORZEYFUL dosage to 0.5 mg twice daily1
  • Maximum recommended total dosage is 1 mg per day1
A pill bottle and tablets icon

Your dosing questions answered

CI=confidence interval; MWT=Maintenance of Wakefulness Test; SD=standard deviation.

Reference: 1. ORZEYFUL (oveporexton tablets) prescribing information. Takeda Pharmaceuticals.